Skip to main content
ASTRO 2024 Main banner
Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis
Back

Phuoc Tran, MD, PhD

University of Maryland
Baltimore, Maryland, United States

Phuoc T. Tran, MD, PhD, is Professor and Vice Chair for Research of Radiation Oncology at the University of Maryland. Phuoc is a board-certified radiation oncologist and clinically specializes in treatment of GU malignancies. Phuoc received his MD-PhD from OHSU, completed radiation oncology residency and postdoctoral fellowship at Stanford. Phuoc’s training focused on DNA repair, cancer biology, and transgenic mouse models. His laboratory research funded by the NIH, DoD and foundations focuses on tumor cell epithelial plasticity programs, novel agents to enhance the local and systemic effects of radiation and the oligometastatic state, all to improve the outcomes of patients with cancer. He is the contact PI for the NCI funded U54 ROBIN Oligo-metastasis Center and also leads an active clinical trials program that includes interventional and translational investigator-initiated studies. He is the NRG Oncology GU Translational Science chair and ASTRO Research Funding Development Committee chair. He has received numerous awards for his research and clinical work from the RSNA, ASTRO, the Sidney Kimmel Foundation, the American Cancer Society, Uniting Against Lung Cancer, American Lung Association, the Movember Foundation, the Prostate Cancer Foundation and was voted a Top Doctor in Baltimore Magazine. He also serves as a Senior Editor for Cancer Research.

Disclosures:

  • Employment: University of Maryland School of Medicine:Professor & Vice Chair:Employee
  • Compensation: Bayer Healthcare: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: present ;Lantheus: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 6/1/23 ;Natsar Pharmaceuticals: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: present ;Pfizer: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 12/1/23 ;Regeneron: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: 3/1/2023 ;Janssen: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Honoraria-End Date: present ;RefleXion Medical Inc: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Honoraria, Travel Expenses-End Date: present
  • Ownership: Natsar Pharmaceuticals:Copyright
  • Leadership: AACR:Radiation Science and Medicine Working Group Steering Committee;Cancer Resesarch:Senior Editor;NRG Oncology:GU TS Chair

Presentation(s):